H3 K27M clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Sorry, not currently recruiting here
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend…
at UC Irvine UCLA UCSD UCSF
Last updated: